Vector 👻 | $10,000,000 | (May 14, 2026)
Avant Genomics | $3,000,000 | (May 14, 2026)
Data Mission | $1,000,000 | (May 14, 2026)
Certified by Founder
Lodge
Altesa BioSciences, Inc.
start up
United States
- Atlanta, GA
- 20/02/2026
- Series B
- $75,000,000
Altesa is an innovative, clinical-stage pharmaceutical company dedicated to preventing and treating the leading cause of COPD and asthma exacerbations -- namely viral respiratory infections -- starting with rhinovirus, the most common respiratory virus on the planet.
Our goal is to disrupt the COPD treatment paradigm by targeting the upstream cause of acute respiratory exacerbations -- not accept the status quo of managing the long term downstream consequences like chronic inflammation, hospitalizations and even death.
- Industry Biotechnology Research
- Website https://www.altesabio.com/
- LinkedIn https://www.linkedin.com/company/altesa-biosciences/
SwishX | $2,200,000 | (May 14, 2026)
Dolfin | $2,460,580 | (May 14, 2026)
4AM | $4,000,000 | (May 13, 2026)
Sedivention - Freezing the hunger feeling | $3,402,541 | (May 13, 2026)
Meatly | $14,074,996 | (May 13, 2026)
NanoStruct GmbH | $3,050,853 | (May 13, 2026)
Adfin | $18,000,000 | (May 13, 2026)
Boundary | $2,000,000 | (May 13, 2026)
Knit Health | $11,600,000 | (May 13, 2026)